News Feed
Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study
Science in Action confirmed that they have received ethics approval for an in-vivo non-GLP toxicology study of N, N Dimethyltryptamine (DMT). […]
News Feed
News Feed
ArcPacific Resources Announces AGSM Results
Following the Meeting, Mr. Adrian Smith, Mr. Collin Kim, Mr. Ken Chung, Mr. Kosta Tsoutsis and Mr. Mike Collins will serve on the board of directors. […]
News Feed
XORTX to Present at BIO CEO and Investor Conference; Strategies to Decrease Acute and Chronic Kidney Injury, Co-morbidity and Mortality
The Company is participating in the BIO CEO and Investor Digital Conference to be held virtually February 16-18, 2021. […]
News Feed
Entheon Biomedical Hires ClearTV Executive as VP of Digital Experience Entertainment Veteran Jonna Birgans to Oversee Digital and VR Content Development
Vancouver, British Columbia–(Newsfile Corp. – February 4, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTC PINK: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, is […]
News Feed
CANAQUEST SIGNS MENTANINE® AND MENTABINOL® PRODUCTION AND DISTRIBUTION AGREEMENT WITH PURCANN PHARMA AND SILICYCLE INC.
PurCann, a subsidiary of SiliCycle, is recognized for its unique expertise in the Extraction-Purification and commercialization of cannabinoids. […]
News Feed
Sigyn Therapeutics Appoints Eric Lynam as Head of Clinical Affairs
Mr. Lynam to Oversee Clinical Studies of Sigyn Therapy™ to Treat Life-Threatening Inflammatory Conditions […]
News Feed
Eastern Platinum Limited to Invest in Growth with Completed Rights Offering
Eastplats issued 36,841,741 common shares of the Company (each a “Common Share”) at a price of CDN$0.32 per Common Share […]
News Feed
Entheon Biomedical to be Included in First North American Psychedelic ETF
Vancouver, British Columbia–(Newsfile Corp. – January 22, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTC Pink: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic medicines to treat addiction, is […]
News Feed
Entheon Biomedical Partners with Divergence Neuro Technologies Inc. for Predictive Biomarker Platform Development
Vancouver, British Columbia–(Newsfile Corp. – January 19, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (OTC Pink: ENTBF) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, announced […]
News Feed
Recent Milestone Achievements of Sigyn Therapeutics Discussed During CEO Interview
During the interview, Mr. Joyce discusses recent data-driven milestones that reinforce the potential for Sigyn Therapy™ to overcome the limitations of previous strategies to treat sepsis and other life-threatening inflammatory conditions. […]